Conexiant
Login
  • Corneal Physician
  • Glaucoma Physician
  • New Retinal Physician
  • Ophthalmology Management
  • Ophthalmic Professional
  • Presbyopia Physician
  • Retinal Physician
The Ophthalmologist
  • Explore

    Explore

    • Latest
    • Insights
    • Case Studies
    • Opinion & Personal Narratives
    • Research & Innovations
    • Product Profiles

    Featured Topics

    • Anterior Segment
    • Glaucoma
    • Retina

    Issues

    • Latest Issue
    • Archive
  • Subspecialties
    • Cataract
    • Cornea
    • Glaucoma
    • Neuro-ophthalmology
    • Oculoplastics
    • Pediatric
    • Retina
  • Business

    Business & Profession

    • Professional Development
    • Business and Entrepreneurship
    • Practice Management
    • Health Economics & Policy
  • Training & Education

    Career Development

    • Professional Development
    • Career Pathways

    Events

    • Webinars
    • Live Events
  • Events
    • Live Events
    • Webinars
  • Community

    People & Profiles

    • Power List
    • Voices in the Community
    • Authors & Contributors
  • Multimedia
    • Video
    • Podcasts
Subscribe
Subscribe

False

Advertisement
The Ophthalmologist / Power List / 2023 / Honorees / Michael Belkin

Michael Belkin

  • Profile

About Michael Belkin

Professor Emeritus of Ophthalmology, Goldschleger Eye Research Institute, Tel Aviv University, Israel

What is an interesting or little-known fact about you?

Sorry, that information is classified…

Wy did you decide to pursue ophthalmology/your subspecialty?

When I started in medicine there were no IOLs,  so we operated when the patients had severe visual impairment. It was an incredible experience to see a  person  coming  in  practically  blind and leaving with eyesight

What’s been the biggest breakthrough in ophthalmology/your specific field over the last 10 years?

In terms of a colossal breakthrough, it must be anti-VEGF for retinal diseases. 

Do you have any strong opinions with which the rest of the field tends to disagree?

Yes – the importance of neuroprotection for retina and CNS diseases.

What would you like to see change in ophthalmology/your subspecialty over the next 10 years?

The biggest change in glaucoma would be to continue the transition from topical drug therapy to laser/surgical treatment. 

Do you have a personal mission for the next ten years?

I refer you to my answer in the previous question.

Who would you invite to your dream dinner party?

My wife is all I need! 

Explore More in Ophthalmology

Dive deeper into the world of Ophthalmology. Explore the latest articles, case studies, expert insights, and groundbreaking research.

Newsletters

Receive the latest Ophthalmology news, personalities, education, and career development – weekly to your inbox.

Newsletter Signup Image

False

Advertisement

False

Advertisement

False

Advertisement
The Ophthalmologist
Subscribe

About

  • About Us
  • Work at Conexiant Europe
  • Terms and Conditions
  • Privacy Policy
  • Advertise With Us
  • Contact Us

Copyright © 2025 Texere Publishing Limited (trading as Conexiant), with registered number 08113419 whose registered office is at Booths No. 1, Booths Park, Chelford Road, Knutsford, England, WA16 8GS.

Disclaimer

The Ophthalmologist website is intended solely for the eyes of healthcare professionals. Please confirm below: